ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer

por Yang, JianYu, Xu, Yu, Huo, YanMiao, Cai, Li, Hua, Rong, Zhang, JunFeng, Chen, Zhong
Publicado 2021

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma

por Yang, Jian-Yu, Jiang, Shu-Heng, Liu, De-Jun, Yang, Xiao-Mei, Huo, Yan-Miao, Li, Jiao, Hua, Rong, Zhang, Zhi-Gang, Sun, Yong-Wei
Publicado 2015

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma

por Yang, Jian-Yu, Jiang, Shu-Heng, Liu, De-Jun, Yang, Xiao-Mei, Huo, Yan-Miao, Li, Jiao, Hua, Rong, Zhang, Zhi-Gang, Sun, Yong-Wei
Publicado 2015

Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review

por Liu, Wei, Fu, Xue-Liang, Yang, Jian-Yu, Liu, De-Jun, Li, Jiao, Zhang, Jun-Feng, Huo, Yan-Miao, Yang, Min-Wei, Hua, Rong, Sun, Yong-Wei
Publicado 2016

CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer

por Guo, Jun-Chao, Li, Jian, Zhou, Li, Yang, Jian-Yu, Zhang, Zhi-Gang, Liang, Zhi-Yong, Zhou, Wei-Xun, You, Lei, Zhang, Tai-Ping, Zhao, Yu-Pei
Publicado 2016

Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma

por Fu, Xue-Liang, Liu, De-Jun, Yan, Ting-Ting, Yang, Jian-Yu, Yang, Min-Wei, Li, Jiao, Huo, Yan-Miao, Liu, Wei, Zhang, Jun-Feng, Hong, Jie, Hua, Rong, Chen, Hao-Yan, Sun, Yong-Wei
Publicado 2016

SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A–c‐Myc axis

por Yang, Jian‐Yu, Huo, Yan‐Miao, Yang, Min‐Wei, Shen, Yang, Liu, De‐Jun, Fu, Xue‐Liang, Tao, Ling‐Ye, He, Rui‐Zhe, Zhang, Jun‐Feng, Hua, Rong, Jiang, Shu‐Heng, Sun, Yong‐Wei, Liu, Wei
Publicado 2021

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma

por Zheng, Jia-Hao, Yao, Hong-Fei, Duan, Zong-Hao, Ji, Pei-Xuan, Yang, Jian, Zhu, Yu-Heng, Jia, Qin-Yuan, Yang, Jian-Yu, Liu, De-Jun, Sun, Yong-Wei, Chen, Peng-Cheng, Shi, Pei-Dong, Chen, Li
Publicado 2022

High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation

por Shen, Chao-qin, Yan, Ting-Ting, Liu, Wei, Zhu, Xiao-qiang, Tian, Xiang-long, Fu, Xue-liang, Hua, Rong, Zhang, Jun-feng, Huo, Yan-miao, Liu, De-jun, Yang, Jian-yu, Sun, Yong-Wei, Fang, Jing-Yuan, Chen, Hao-Yan, Hong, Jie
Publicado 2017

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas

por Yang, Min-Wei, Fu, Xue-Liang, Jiang, Yong-Sheng, Chen, Xiao-Jing, Tao, Ling-Ye, Yang, Jian-Yu, Huo, Yan-Miao, Liu, Wei, Zhang, Jun-Feng, Liu, Pei-Feng, Liu, Qiang, Hua, Rong, Zhang, Zhi-Gang, Sun, Yong-Wei, Liu, De-Jun
Publicado 2019

Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis

por Wang, Xu, Hu, Li-Peng, Qin, Wei-Ting, Yang, Qin, Chen, De-Yu, Li, Qing, Zhou, Kai-Xia, Huang, Pei-Qi, Xu, Chun-Jie, Li, Jun, Yao, Lin-Li, Wang, Ya-Hui, Tian, Guang-Ang, Yang, Jian-Yu, Yang, Min-Wei, Liu, De-Jun, Sun, Yong-Wei, Jiang, Shu-Heng, Zhang, Xue-Li, Zhang, Zhi-Gang
Publicado 2021

Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer

por Jiang, Shu-Heng, Wang, Yang, Yang, Jian-Yu, Li, Jun, Feng, Ming-Xuan, Wang, Ya-Hui, Yang, Xiao-Mei, He, Ping, Tian, Guang-Ang, Zhang, Xiao-Xin, Li, Qing, Cao, Xiao-Yan, Huo, Yan-Miao, Yang, Min-Wei, Fu, Xue-Liang, Li, Jiao, Liu, De-Jun, Dai, Miao, Wen, Shan-Yun, Gu, Jian-Ren, Hong, Jie, Hua, Rong, Zhang, Zhi-Gang, Sun, Yong-Wei
Publicado 2015